Aemetis, Inc. (NASDAQ:AMTX) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
release announcing its earnings for the quarter ended March 31,
2017. Aemetis will also host an earnings review call on May 11,
2017 at 11:00 am Pacific (PT). For details on the call, visit:
Current Report on Form8-K and is incorporated herein by
reference.
and not filed for purposes of Section18 of the Securities
Exchange Act of 1934, as amended, and shall not be incorporated
by reference into any registration statement of the issuer.
web site at www.aemetis.com, announcing its earnings for the
quarter ended March 31, 2017, a copy of which is filed as Exhibit
99.1 hereto and incorporated herein by reference.
|
EXHIBITNUMBER
|
DESCRIPTION
|
|
|
Exhibit 99.1
|
Earnings Release dated May 11, 2017
|
|
About Aemetis, Inc. (NASDAQ:AMTX)
Aemetis, Inc. is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries. Its segments include North America and India. The North America segment includes the Company’s approximately 60 million gallon per year capacity ethanol manufacturing plant in Keyes, California and its technology lab in College Park, Maryland. The India segment includes the Company’s over 50 million gallon per year capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Keyes plant produces denatured ethanol, Wet Distillers Grains, corn oil and Condensed Distillers Solubles. It produces biodiesel and refined glycerin at the Kakinada plant. Aemetis, Inc. (NASDAQ:AMTX) Recent Trading Information
Aemetis, Inc. (NASDAQ:AMTX) closed its last trading session 00.00 at 1.48 with 677,599 shares trading hands.
